abstract: Heat shock protein (HSP27) is expressed in human placentae. Previously, we showed that HSP27 is expressed in the villous cell column of first trimester placental explants and in extravillous trophoblast (EVT) cells. EVT differentiation is accompanied by increased motility, matrix metalloproteinase (MMP) activity, decreased proliferation and expression of specific markers such as HLAG and CD9. HSP27 regulates cell apoptosis, migration, protein stability and the availability of eukaryotic translation initiation factors, such as eukaryotic translation initiation factor 4E (eIF4E). eIF4E supports trophoblast cell proliferation and survival. We wanted to explore the effect of HSP27 silencing on trophoblast cell phenotype, EVT markers and eIF4E expression and regulators [4E-binding protein (4E-BP1) and MAP kinase-interacting kinase (MNK1)]. This study evaluated the effect of HSP27 siRNA on placental explant and HTR-8/SVneo migration, MMP activity/mRNA, cell death, cell cycle, HLAG/ CD9 levels, and eIF4E and its regulators' total and phosphorylated levels. Furthermore, we evaluated HSP27 levels in placentae exposed to ribavirin, which triggers EVT differentiation. We found that HSP27 silencing increased cell death in HTR-8/SVneo and placental explants. Furthermore, it reduced HTR-8/SVneo migration and EVT outgrowth from the explants (P , 0.05), MMP2 activity and expression of EVT markers HLAG and CD9 (in placental explants and HTR-8/SVneo, respectively, P , 0.05). Induction of EVT differentiation by ribavirin elevated HSP27 levels. Finally, HSP27 silencing in both HTR-8/SVneo and placental explants reduced eIF4E levels (33 and 28%, respectively, P , 0.05) and the levels of its regulators 4E-BP1 and MNK1 (37 and 32%, respectively, done on HTR-8/SVneo only), but not their phosphorylated forms. Altogether, our results suggest that HSP27 contributes to EVT cell differentiation.
Introduction
Heat shock protein 27 (HSP27) is a small heat shock protein that is constitutively abundant and ubiquitously present (Arya et al., 2007) . Its expression can vary during development, cell cycle and cell differentiation (Parcellier et al., 2005) . HSP27 is expressed in the human placenta. It is expressed exclusively in the syncytiotrophoblast layer in term placentae (Mineva et al., 2008) and in the syncytiotrophoblast and intermediate trophoblast cells in the first two trimesters of pregnancy (Shah et al., 1998; Matalon et al., 2008) . Previously, we showed that in first trimester human placental explants, HSP27 is not expressed in cytotrophoblast cells, but it is expressed in the cytoplasm and the nucleus of trophoblast cells in the villi cell columns. Interestingly, its expression is decreased and localization changed only at the cytoplasm/membrane of the differentiated extravillous trophoblast (EVT) cells. EVT cells are main players in placental implantation. They invade the uterine decidual spiral arterioles and mediate remodeling of these vessels. During differentiation to EVT, trophoblast cells proliferate in the cell columns, acquire invasive tools such as matrix metalloproteinases (MMPs) and express specific markers such as CD9 and HLAG (Ji et al., 2013) . Previously, we found that HSP27 expression is modulated in concordance with EVT migration and MMP2 activity (Matalon et al., 2008) , suggesting that it may affect † Equal contribution. trophoblast cell differentiation to motile cells. Moreover, altered HSP27 levels in pathological pregnancy conditions have been reported, including elevated HSP27 levels in preeclamptic placentae (PET; Shin et al., 2011) and reduced HSP27 expression in placentae of small for gestational age (IUGR) newborns (Canete et al., 2012) . Together with the failure to obtain HSP27 knockout mice (Garrido, 2002) , these data suggest that this protein is essential for placentation.
HSP27 has various roles that include increasing cell resistance to stress (Arrigo, 2001) , regulating cell death (Acunzo et al., 2012) and the assembly of protein complexes, modulating the proteasome pathway and regulating cell motility by controlling cytoskeletal architecture (Chen et al., 2009; Li et al., 2011; Jones et al., 2012) . Recent studies suggest that HSP27 mediates the availability of protein translation initiation factors (Doerwald et al., 2006; Andrieu et al., 2010) . Translation initiation encompasses recruitment of the eukaryotic translation initiation complex eIF4F, which is composed of the cap-binding unit, eukaryotic translation initiation factor 4E (eIF4E), scaffolding protein eIF4G and ATP-dependent RNA helicase eIF4A. eIF4E is rate limiting to 5 ′ capdependent protein translation (Doerwald et al., 2006; Chen et al., 2009) , and it contributes to the nuclear-to-cytoplasmic transport of some mRNAs (Rosenwald et al., 1995; Culjkovic et al., 2005; Phillips and Blaydes, 2008; Silva and Wendel, 2008) . It preferentially enables the translation of a limited pool of mRNAs that contain highly structured 5-untranslated region (De Benedetti and Graff, 2004) . These include some tightly regulated genes that control cell cycle, apoptosis, invasion and angiogenesis, such as cyclin D1, c-Myc and MMP9, all of which are often overexpressed in the placenta and cancer (Ferretti et al., 2007) . eIF4E activity is tightly regulated, by both phosphorylation and inhibitor binding. Among its regulators are the factor 4E-binding protein (4E-BP1) and MNK1. 4E-BP1 competes with eIF4G for a shared binding site on eIF4E. It is bound to the eIF4E, preventing its activity, but following 4E-BP1 phosphorylation by mTOR, it is disconnected allowing assembly of the translation initiation complex (eIF4E-eIF4G-eIF4A) (Silva and Wendel, 2008; Sonenberg and Hinnebusch, 2009 ). MNK1 phosphorylates and activates eIF4E (Sonenberg and Hinnebusch, 2009 ). In our previous study, we observed high eIF4E levels in cytotrophoblast and in EVT cells during their differentiation in the villi and low expression in the differentiated EVT cells located out of the villi (Kitroser et al., 2012) . We suggested that eIF4E manipulation contributes to trophoblast differentiation. Like eIF4E, HSP27 is expressed in trophoblast cells during differentiation, but at a lower level at the differentiated EVT cells. Moreover, both HSP27 and eIF4E molecules strongly affect the protein repertoire. Thus, we speculated that HSP27 affects eIF4E levels and/or activity in the placental cells. In the current study, we analyzed the importance of HSP27 to the first trimester human placenta EVT cell phenotype and to the translation initiation process. Thus, we silenced HSP27 in first trimester human placental explants and in the trophoblast cell line (HTR-8/SVneo) and then tested their phenotype and differentiation markers (CD9 and HLAG), as well as eIF4E expression and its regulators.
Materials and methods

Placental explant culture
Culture techniques were based on studies of Genbacev et al. (1992; . Placentae at 6 -9 weeks of gestation were retrieved from healthy pregnancies terminated for psychosocial reasons.
Immediately after pregnancy termination, part of each placenta was paraffin embedded or frozen (2808C). The remainder was used for placental explant culture. Placental explants of 10 mg wet weight were transferred into inserts (Millipore, Carrigtwohill Co., Cork, Ireland) previously layered with Matrigel TM (BD Biosciences, Bedford, MA, USA) and placed into 24-well culture dishes. Ninety minutes later, 700 ml medium Dulbecco's modified Eagle's medium (DMEM)/F-12 (HAM), L-glutamine (2 mM), sodium pyruvate (1 mM), HEPES (25 mM), antibiotics, and 10% fetal calf serum (Biological Industries, Beit Haemek, Israel) was added to the bottom of the culture dish. The next day, medium was added to cover the culture inserts. After 24 h, a portion of the explants were 'snap-frozen' in liquid nitrogen (2808C) and media were replaced. After an additional 48 h, the remaining villi were frozen (2808C) or fixed with formaldehyde and paraffin embedded. Placental samples from three to six different women were used in each experiment.
Cell culture
HTR-8/SVneo cells (immortalized first trimester EVT cells, kindly provided by Dr Charles H. Graham, Queen's University, Kingston, Canada) were grown in DMEM (supplemented with L-glutamine (2 mM), fetal calf serum (10%) and antibiotics) (Biological Industries).
Immunohistochemistry
Paraffin sections were deparaffinized in xylene and alcohol, rinsed in phosphate-buffered saline (PBS), immersed in EDTA buffer (pH 8) and heated for 15 min. Endogenous peroxidase activity was quenched in 3% H 2 O 2 (diluted in PBS). Samples were blocked using goat serum and incubated with primary antibodies overnight (48C, Table I ). Following washing, slides were incubated with horseradish peroxidase labeled polymer conjugated to secondary antibody (Table I) , washed and developed with AEC chromogen system (Covance Research Products, Dedham, MA, USA). Isotypematched control antibodies excluded non-specific staining.
siRNA transfection into HTR-8/SVneo cells
Commercial validated Alexa-labeled AllStars negative control and HSP27 siRNAs (Qiagen, Valencia, CA, USA). Transfection efficiency was assayed by FACS using the Alexa fluorescent tag and was repeated independently for each experiment. Cells (50 000/well) were grown for 24 h in 500 ml of medium. Then, 100 ml Optimem (GIBCO, Life Technologies, Carlsbad, CA, USA), 1.7 ml lipofectamine 2000 (Invitorgene, CA, USA) and 20 pmol siRNA were mixed according to lipofectamine protocol and added to the cells. Cells were cultured for 48, 72 and 96 h.
Introducing siRNA/ribavirin to placental explants
Immediately after dissection from the placenta, the villi were incubated in culture media supplied with 100 ml Optimem, 1.7 ml lipofectamine and 20 pmol of siRNA or ribavirin (10 mM, Sigma) for 90 min. Then, explants were washed and cultured as described above in the Placental explant culture section. Similar concentrations of siRNA were added to culture dish bottoms and to media covering the explants for rest of the experiment.
Protein extraction
HTR-8/SVNEO cells were lysed (10 min, 48C) in a buffer [25 mM Tris (pH 7.5), 1% Triton X-100, 0.5 mM EDTA, 150 mM NaCl, 10 nM NaF, 10 mg/ml leupeptin, 10 mg/ml pepstatin, 200 mg/ml phenylmethylsulphonyl fluoride, and a 1:100 phosphatase inhibitor cocktail] for 10 min on ice. The 'snapfrozen' placental tissue (5 mg) was homogenized in the same lysis buffer (150 ml). The homogenizer was rinsed with additional 100 ml of lysis buffer. The tube was maintained in constant agitation for 2 h at 48C.
Analyzing the effect of HSP27 on placenta Protein concentration was determined with BCA TM protein assay KIT (Thermo Scientific, Rockford, IL, USA) according to manufacturer instructions.
Western blotting
Equal protein amounts (experiment and control) were denatured (5 min, 958C) and separated on SDS -PAGE followed by a wet transfer to a polyvinylidene difluoride membrane. The membrane was blocked (5% dry milk) and incubated with primary antibodies (Table I) at 48C overnight. Horseradish peroxidase (HRP)-conjugated secondary antibodies were added (1.5 h room temperature) and visualized by enhanced chemiluminescence kit (ECL, Millipore, Billerica, MA, USA). Optical densities of immunoreactive bands were measured as arbitrary units with an LAS3000 Imager (Fugifilm, Greenwood, SC, USA). Results were normalized to Tubulin values using the Multi-gauge V3.0 program.
Cell survival and death
HTR-8/SVneo cell survival was determined by flow cytometry (Navios, Beckman Coulter, Inc., Indianapolis, IN, USA). Cells were harvested and stained with Annexin V-PE (250 mg/ml) (BioVision, Milpitas, CA, USA) and 7AAD (0.05 mg/ml; eBioscience, San Diego, CA, USA). Annexin V has a specific affinity for phosphatidylserine (PS) and it monitors the phosphatidylserine translocation that occurs during apoptosis. 7AAD is a fluorescent compound that does not pass through intact cell membrane. Thus, cells that were positive for Annexin V but not for 7AAD, must have had PS on the outer membrane and were considered apoptotic, whereas cells that were positive for both Annexin V and 7AAD were considered necrotic or late apoptotic.
Cell cycle
Transfected HTR-8/SVneo cells were fixed (1 h, 48C, 0.5% formaldehyde, 0.1% sodium azide in PBS), perforated at 2208C in 70% ethanol and exposed to 40 mg/ml propidium iodide (PI, Sigma-Aldrich, St. Louis, MO, USA) and 100 mg/ml Ribonuclease A (Sigma-Aldrich) in PBS for 30 min at room temperature in the dark, and analyzed by flow cytometry.
Scratch test
After 48, 72 and 96 h of transfection, HTR-8/SVneo cells were harvested, washed, counted and cultured for 24 h in 96-well plates to allow cell adhesion (3-wells per treatment). Confluent cells were wounded by manually scraping the cells with a pipette tip. Cells were photographed immediately after wounding (time 0), and after 22 h. The size of the wound was measured at time 0 and time 22 h using ImageJ software: http://rsbweb.nih.gov/ij. Results were presented as the relative percent of closure, compared with time 0.
Assessment of EVT cell invasion from placental explants
Assessment was done as previously described (Matalon et al., 2005) . Briefly, placental explant cultures were examined daily under a microscope (Olympus IX71). To assess EVT migration into the Matrigel TM , each placental explant was divided into 12 sectors (like a clock). EVT cell migration from the placenta to the Matrigel TM was identified by microscopic observation and appeared as finger-like outgrowth projections that surround the placental explants and were located very close to the villous area/surface 
Gelatin zymography
Aliquots (40 ml) of culture media and of standard activated and proactivated MMP9/2 (Chemicon, Temecula, CA, USA) were electrophoresed at nonreducing conditions in 10% polyacrylamide gels containing 1 mg/ml gelatin type A (Sigma-Aldrich). Gels were washed twice in 2.5% Triton X-100 and incubated overnight in 50 mM Tris -HCl (pH 7.5) and 5 mM CaCl 2 . Coomassie blue staining, followed by destaining (20% methanol, 7% acetic acid in double-distilled water) allowed visualization of clear lysis zones. Optical densities were measured as arbitrary units by using an LAS3000 Imager.
Results were normalized to background values using the Multi-gauge V3.0 program.
Real-time quantitative PCR
Specific primers were designed according to Primer Express 3.0 software specifications. qPCR reactions were done using Power SYBR Green (Applied Biosystems, Warrington, UK). The following primers (Hylabs, Rehovot, Israel) were used: GUSB Forward:
′ . GUSB and b-actin housekeeping genes served as the control. Primers were normalized by specific cDNA standard curves obtained from known amounts of cDNA.
Statistical analyses
Paired Student's t-tests were employed to analyze differences between cohorts. An effect was considered significant when P , 0.05. All experiments were repeated independently at least three times. Results are presented in the figures as Mean + standard error (SEM).
Ethical approval
The use of human tissue was approved by the Helsinki Committee of Meir Medical Centre. Written informed consent was obtained for all placental samples.
Results
HSP27 silencing induced cell death and inhibited EVT cell migration and HLAG expression in placental explants
HSP27 siRNA was introduced into first trimester human placental explants cultured on Matrigel TM . Non-genomic siRNA tagged with Alexa monitored the introduction of the siRNA into the placenta and served as a control. The Alexa tag demonstrated that the siRNA was introduced into the cell columns of the villi and the syncytiotrophoblast layer ( Fig. 1A and B) . Cell columns contain trophoblast cells during their differentiation to EVT cells. HSP27 silencing was confirmed at the protein level by IHC (Fig. 1C) and by western blotting (WB) (33% reduction, P , 0.05, 24 h, Fig. 1D ). The level of the housekeeping gene, Tubulin (relative to protein concentration) did not change after transfection, suggesting a specific action of the HSP27 siRNA. We found that 72 h after transfection, HSP27 silencing significantly induced cell death, as evidenced by elevated levels of phosphorylated P53 ser46 (WB, 56% elevation, P , 0.05, Fig. 2A ) and activated caspase 3 (IHC, Fig. 2B ). There was no effect on cyclin D1 expression (data not shown).
Silencing HSP27 inhibited EVT cell migration from the villi into the Matrigel TM (35% inhibition, 72 h, P , 0.05, Fig. 2C and D). Furthermore, MMP2 activity level in the medium was modestly, but significantly reduced (14% reduction, P , 0.05, Fig. 2E) , whereas MMP9 activity level did not change significantly (elevated in three cases and reduced in two). During EVT cell differentiation to motile cells, trophoblast cells lose their E-cadherin, detach from their neighboring cells, migrate out of the villous and start to express specific markers such as HLAG (Manaster et al., 2012) . Thus, we also analyzed the effect of HSP27 silencing on HLAG and E-cadherin expression in the placental explants. Indeed, we observed reduced HLAG expression by IHC (Fig. 2F) and WB (67% reduction, 72 h, P , 0.05, Fig. 2G ). Furthermore, we found that HSP27 silencing significantly increased E-cadherin expression (Fig. 2G) . Interestingly, this phenomenon was significant only 24 h after transfection. IHC staining showed that E-cadherin expression was higher in EVT cells of placental explants following HSP27 silencing (Fig. 2H) . Altogether, our results showed that HSP27 silencing inhibited EVT cell survival, migration, MMP2 activity and expression of the differentiation marker HLAG, while preventing the decrease in E-cadherin that characterizes EVT differentiation, suggesting inhibition of EVT differentiation.
Ribavirin induced EVT cell differentiation and increased HSP27 expression in placental explants
Previously, we demonstrated that exposing placental explants to ribavirin (an inhibitor of eIF4E activity) facilitated EVT cell outgrowth and HLAG expression, and we suggested that it induced EVT cell differentiation (Kitroser et al., 2012) . As HSP27 was shown to regulate EVT cell differentiation markers, we speculated that ribavirin would also induce HSP27 expression. Indeed, we found that exposing placental explants to ribavirin elevated HSP27 expression, again suggesting that HSP27 contributes to EVT cell differentiation (319% elevation, P , 0.05, Fig. 3 ).
The effect of HSP27 silencing on HTR-8/SVneo cell phenotype
As a next step, we analyzed the effect of HSP27 silencing on the HTR-8/SVneo cell line. This cell line was generated by immortalizing EVT cells via transfection with a plasmid containing the simian virus 40 large T antigen (SV40). The expression profile of trophoblast differentiation markers demonstrated that HTR-8/SVneo cells express vCTB, STB and EVT markers. Furthermore, two recent publications showed that HTR-8/SVneo cells displayed trophoblast progenitor cell characteristics, which might differentiate into multiple trophoblast cell lineages including EVT (Takao et al., 2011; Weber et al., 2013) . Since HSP27 is expressed in EVT cells during their differentiation (Shah et al., 1998; Matalon et al., 2008) and its silencing inhibited EVT cell migration from the villi into the Matrigel TM , we decided to silence HSP27 in the HTR-8/SVneo cells and analyze its effect on cell phenotype and EVT differentiation markers. The transfection efficiency as measured by FACS was 93%. HSP27 silencing was confirmed at the protein level by WB (63 and 84% reduction at 72 and 96 h, respectively; Fig. 4A ). The level of the housekeeping gene, Tubulin (relative to protein concentration) did not change after transfection, suggesting a specific action of the HSP27 siRNA. Using the Annexin V/7AAD method, we found that HSP27 silencing increased HTR-8/SVneo cell death (from 2.1% to 6.7% and from 5.4% to 17.7%, 72 and 96 h after transfection, respectively; Fig. 4B ). Moreover, a small, yet significant elevation in the number of cells in the sub-G1 fraction was found (from 4 to 5% and from 11 to 14%, 72 and 96 h after transfection, respectively, P , 0.05, Fig. 4C ). Since sub-G1 fraction of the cell cycle contains cells that express less than one full copy of the chromosomes, its elevation usually reflects elevated cell death. Similar to the placental explants, no significant effect on cell cycle was found (data not shown). Next, we analyzed the effect of HSP27 silencing on HTR-8/SVneo cell migration. No significant change was observed after 48 and 72 h (Fig. 4E) . However, 96 h after transfection, HSP27 silencing significantly reduced HTR-8/SVneo cell migration (43% reduction, P , 0.05, Fig. 4D and E) . Moreover, we analyzed the effect of HSP27 silencing on MMP2/9 activity and found that MMP2 activity was indeed down-regulated (24% reduction after 48 h and 45% after 72 h, P , 0.05, Fig. 4F ), whereas MMP9 activity was up-regulated (Fig. 4F) . Elevated cell death may itself be the cause of the reduced cell migration and MMP activity. Nevertheless, the elevation in cell death was much smaller ( 12%) than the effect on migration, which supports a specific inhibition of cell migration. In order to find whether the reduced MMP2 activity was a result of a specific reduction in MMP2 transcription or a result of the elevated cell death, we further analyzed the effect of HSP27 silencing on MMP2/9 mRNA levels. As a reference, two housekeeping genes were used (GUSB and b-actin). We found that HSP27 silencing inhibited the mRNA level of MMP2 after 24 h, but had no effect on MMP9 mRNA levels (32% reduction, P , 0.05). The level of the house keeping genes did not change, suggesting a specific inhibition of MMP2 mRNA transcription.
As a next step, we explored whether HSP27 silencing reduced the expression of specific EVT cell markers. EVT cell differentiation is accompanied by elevated MMP activity, reduction in cell proliferation and Figure 1 HSP27 silencing in first trimester placental explants. HSP27 silencing was done using HSP27 siRNA. Alexa-labeled siRNA served as a negative control. In order to validate transfection and silencing, placental explants were photographed by fluorescence microscope and HSP27 expression was measured using western blot and immunohistochemistry. (A and B) Photomicrograph of placental explants exposed to control Alexa-Flour 488 siRNA [light (A) and fluorescent (B), ×40 magnification]. (C) Representative photomicrographs of paraffin sections of placental explants exposed to control/HSP27 siRNA stained for HSP27. (D) HSP27 expression in placental explants exposed to control/HSP27 siRNA by western blot. *Significantly different from control siRNA (P , 0.05, n . 3). Figure 2 The effect of HSP27 silencing on placental explant phenotype. The effect of HSP27 silencing on first trimester human placental explant cell death, EVT cell migration, MMP activity and HLAG/E-cadherin expression was analyzed. (A) Western blot analyses of phospho-P53 Ser46 expression levels of placental explants exposed to control/HSP27 siRNA. (B) Representative photomicrographs of paraffin sections of placental explants exposed to control/ HSP27 siRNA stained for active caspase 3. (C) Evaluation of EVT cell outgrowth from placental explants exposed to control/ HSP27 siRNA. (D) Photomicrograph of placental explants exposed to control/HSP27 siRNA (×40 magnification). (E) Zymogram analyses of MMP2/9 activity in media collected from control/HSP27 siRNA transfected placental explants after 72 h. (F and H) Representative photomicrographs of paraffin sections of placental explants exposed to control/HSP27 siRNA stained for HLAG (F) and E-cadherin (H). (G) Western blot analyses of HLAG and E-cadherin expression levels of placental explants exposed to control/HSP27 siRNA. *Significantly different from control siRNA (P , 0.05, n ≥ 4).
Analyzing the effect of HSP27 on placenta E-cadherin expression, and elevated expression of HLAG and CD9. Thus, we further analyzed the effect of HSP27 silencing on cyclin D1 and CD9 expression (HLAG and E-cadherin were not tested, as they are not expressed in HTR-8/SVneo cells layered on plastic). We found that 48 h after transfection, the level of cyclin D1 was reduced and of CD9 was not significantly changed. However, after 96 h, cyclin D1 level was significantly elevated, while CD9 level was significantly reduced (54% elevation and 45% reduction, respectively, P , 0.05, Fig. 4G ), suggesting that 96 h after transfection, EVT characteristics were inhibited (i.e. increased migration, cyclin D1 reduction and CD9 elevation were all inhibited by the HSP27 silencing).
Altogether, our results with placental explants and with the HTR-8/ SVneo cell line suggest that HSP27 regulates EVT cell death, migration and the expression of specific EVT cell differentiation markers.
The effect of HSP27 silencing on eIF4E level
Earlier studies showed that HSP27 is involved in mediating the availability of the translation initiation factors eIF4E and eIF4G (Doerwald et al., 2006; Andrieu et al., 2010) . HSP27 and eIF4E regulate the protein repertoire and trophoblast cell survival and migration (Doerwald et al., 2006; Kitroser et al., 2012) . As both HSP27 and eIF4E are expressed in EVT cells during their differentiation and are decreased in the differentiated state, we speculated that HSP27 regulates the eIF4E. Indeed, we found that HSP27 silencing reduced the eIF4E level in the placental explants (72 h, WB, 33% reduction, P , 0.05, Fig. 5A and B) . Moreover, HSP27 siRNA significantly reduced eIF4E levels in the HTR-8/SVneo cells after 48 and 72 h (19 and 28% reduction, respectively, P , 0.05, Fig. 5C ). As mentioned above, ribavirin induced a significant elevation in HSP27 levels in the placental explants. Thus, the association between HSP27 and eIF4E expression was further validated by showing a parallel elevation in eIF4E levels in ribavirin-treated placental explants (292% elevation, P , 0.05, Fig. 3 ).
The effect of HSP27 silencing on eIF4E regulators eIF4E activity depends on its level and on its phosphorylated state (Goodfellow and Roberts, 2008) . eIF4E levels and phosphorylation are adjusted by several regulators, including 4E-BP1 (a binding protein that inhibits its activity), its phosphorylated form (which releases eIF4E from its association with 4E-BP1) and MNK1, which phosphorylates and activates eIF4E. Thus, we analyzed the effect of HSP27 silencing in HTR-8/ SVneo on 4E-BP1 and MNK1 levels and on eIF4E, 4E-BP1 and MNK1 phosphorylation. We found that HSP27 silencing significantly decreased the total expression levels of 4E-BP1 and MNK1 (37 and 32% reduction, respectively, P , 0.05, 72 h, Fig. 5C ), but had no effect on the levels of the phosphorylated forms of eIF4E, 4E-BP1 and MNK1 (Fig. 5C ). These results suggest that in addition to the link between HSP27 and eIF4E levels, HSP27 also affects the expression of the eIF4E regulators. These data suggest that HSP27 might be an important regulator of translation initiation in the EVT cells.
Discussion
In the current study, we analyzed the effect of HSP27 silencing on first trimester human placental explants and on a trophoblast cell line. We tested its effect on phenotype, EVT markers, eIF4E expression and the level of eIF4E regulators. We found that HSP27 silencing for 72-96 h impaired trophoblast cell survival and motility and reduced the level of EVT markers, HLAG and CD9. Moreover, it reduced eIF4E level and the levels of its inhibitors 4E-BP and MNK1, but not their phosphorylated forms.
The ability of HSP27 to inhibit cell death was previously found in other biological systems (Acunzo et al., 2012) . HSP27 intervenes in the modulation of cell death pathways by interacting with various components of the cell death machinery and preventing apoptosis in different lethal stress situations (Acunzo et al., 2012) . The ability of HSP27 to regulate cell migration was demonstrated in normal and cancer cells (Shiota et al., 2013) . It affects migration of vascular smooth muscle cells (Chen et al., 2009) and of several cancer cell types, among them prostate and breast (Wei et al., 2011; Shiota et al., 2013) . In both breast and prostate cancers, HSP27 promotes cancer cell differentiation from epithelial to mesenchymal cells with migratory ability (EMT process) (Wei et al., 2011; Shiota et al., 2013) . This process resembles the one that occurs during cytotrophoblast cell differentiation from epithelial to EVT cells that invade the maternal decidua (Kokkinos et al., 2010) . During this process, cytotrophoblast cells detach from their neighboring cells, a process that is accompanied by a decrease in the adherent junction protein E-cadherin, and start to express markers such as CD9 and HLAG. We showed that in addition to the ability of HSP27 silencing to inhibit cell migration and MMP2 activity, it also reduced HLAG/CD9 expression and up-regulated E-cadherin expression, suggesting that it impaired EVT cell differentiation. This observation is also supported by Figure 3 Ribavirin elevates HSP27 and eIF4E levels in placental explants. In order to further establish the connection between HSP27, cell differentiation and eIF4E expression, we exposed first trimester human placental explants to ribavirin (10 mM, 72 h) that facilitates EVT cell differentiation. Its effects on HSP27 and eIF4E expression were analyzed using western blot. *Significantly different from control siRNA (P , 0.05, n ≥ 4). the use of ribavirin. Previously, we showed that ribavirin facilitated EVT cell differentiation (Kitroser et al., 2012) . In the current study, we demonstrated that in addition to inducing EVT cell differentiation, ribavirin also induced elevated HSP27 expression. Moreover, HSP27 silencing reduced MMP2 activity, but elevated MMP9 activity. These data can explain our previous observation of a positive correlation between HSP27 expression in trophoblast cells and MMP2 activity, but not to MMP9 activity (Matalon et al., 2008) .
Previous studies showed that the outgrowth potential of first trimester placental explants significantly correlates with MMP2 activity (Staun-Ram Analyzing the effect of HSP27 on placenta Onogi et al., 2011) . Thus, the ability of HSP27 silencing to inhibit MMP2 activity may explain the reduced outgrowth of EVT cells to the Matrigel TM . HSP27 silencing had no effect on cyclin D1 expression in the placental explants, but it significantly decreased (48 h) and increased (96 h) cyclin D1 expression in HTR-8/SVneo cells. Interestingly, similar results were obtained in our previous study (Kitroser et al., 2012) . There, eIF4E silencing inhibited cyclin D1 expression in HTR-8/SVneo cells, but had no effect on its expression in placental explants. We demonstrated that this contradictory outcome was a result of efficient HSP27 silencing in the HTR-8/SVneo cells versus the limited ability of the siRNA to penetrate deeply into the villi in the area of cell proliferation.
The time-scale and localization of HSP27 and eIF4E expression in the placenta is interesting. eIF4E is highly expressed in the proliferating cytotrophoblast cells in the villi, whereas no HSP27 is found in these cells. However, both HSP27 and eIF4E are expressed at the villous cell column and their level is decreased in the differentiated cells. Our results showed that HSP27 affects eIF4E levels and might explain the fact that both eIF4E and HSP27 expression is decreased in the differentiated EVT cells. However, they cannot explain the absence of HSP27 expression in the cytotrophoblast cells that express eIF4E.
Previous study with cancer cells showed that HSP27 co-localizes and interacts directly with eIF4E (Andrieu et al., 2010) . They also demonstrated that HSP27-eIF4E interaction decreases eIF4E ubiquitination and proteasomal degradation (Andrieu et al., 2010) . This may explain the lower eIF4E level in placental explants and in the EVT cell line after HSP27 silencing. If this assumption is true, then the expression of eIF4E in the cytotrophoblast cells that lack HSP27 should be explained by other eIF4E regulators.
Previously, we showed that eIF4E silencing or inhibiting its activity with ribavirin, facilitated EVT cell outgrowth from the placental explants (Kitroser et al., 2012) . Thus, we expected that the lower eIF4E levels found in placental explants with the silenced HSP27 would enhance EVT migration. However, the opposite occurred. Several possibilities Figure 5 The effect of HSP27 silencing on eIF4E expression and its regulators. In order to further establish the connection between HSP27 and eIF4E expression, we analyzed the effect of HSP27 silencing on total and phosphorylation levels of eIF4E and its regulators MNK1 and 4EBP1 using western blot. (A) Representative photomicrographs of paraffin sections of placental explants exposed to control/HSP27 siRNA stained for eIF4E. (B) Western blot analyses of eIF4E expression levels of placental explants exposed to control/HSP27 siRNA. (C) Western blot analyses of total and phosphorylated expression levels of eIF4E, 4EBP1 and MNK1 of HTR8/SVneo cells exposed to control/HSP27 siRNA. *Significantly different from control siRNA (P , 0.05, n ≥ 4). might explain these contradictory results. First, it took 72 h for HSP27 siRNA to decrease the eIF4E level in the placental explant model, which may be too late to affect EVT migration. Secondly, although HSP27 protects eIF4E from degradation, its effect on eIF4E activity is unknown. Similar to HSP27, 4E-BP1 also interacts with eIF4E and prevents its degradation by the proteasome system (Murata and Shimotohno, 2006) . However, it also inhibits translation activity by preventing the interaction of eIF4G with eIF4E and the formation of the translation initiation complex eIF4F. The situation with HSP27 could be similar: it might protect eIF4E from degradation, but at the same time prevent formation of the eIF4F complex. Indeed, our results showed that after 96 h, the levels of cyclin D1 and MMP9 (both eIF4E targets) were elevated. Previous literature also supports this idea. Overexpression of HSP27 inhibits the interaction of eIF4E with 4E-BP1 (Andrieu et al., 2010) , which may point to a common interaction site. The ability of HSP27 to inhibit translation is also demonstrated in its capability to interact with eIF4G during heat shock and as a result prevent assembly of the eIF4F complex (Cuesta et al., 2000) . If this assumption is true, then the absence of HSP27 in the villi of the cytotrophoblast cells might permit eIF4E activity that would support cytotrophoblast cell proliferation; a hypothesis yet to be proved. The contribution of the HSP27-eIF4E axis to EVT cell differentiation should be explored further.
Interestingly, HSP27 is also highly expressed in the syncytiotrophoblast layer; however, its function in these cells was not the focus of this study. In placentae from IUGR and PET pregnancies, HSP27 levels are aberrant (Shin et al., 2011; Canete et al., 2012) . The connection between the aberrant HSP27 levels and the phenotype of these pathologies is unknown. The elevated HSP27 level in PET placentae may be a response of the placentae to stress and hypoxia. Indeed, trophoblast apoptosis is elevated in pregnancies complicated by pre-eclampsia (Longtine et al., 2012) and HSP27 may prevent some of these events. However, this explanation does not clarify the lower HSP27 levels found in IUGR. Another possibility is that aberrant HSP27 levels might contribute to the development of these pathologies. A major pathological abnormality in PET and IUGR placentae is insufficient maternal spiral artery remodeling (Kaufmann et al., 2003; Khankin et al., 2010; Young et al., 2010) . This is due to a defective invasion of the trophoblast cells (Khankin et al., 2010) , which may reflect impaired EVT cell differentiation. Indeed, a few studies speculated that the epithelial to mesenchymal transition (EMT)-like differentiation of the trophoblast cells is compromised in these placental disorders (PET and IUGR) compared with normal placentae (Kokkinos et al., 2010) . Our results suggest that HSP27 regulates EVT function and the expression of their differentiation markers; thus, its aberrant expression in PET and IUGR pathologies may be the cause for the impaired trophoblast cell differentiation. Interestingly, HSP27 is up-regulated in PET and down-regulated in IUGR placentae. This may reflect differences in the mechanisms and causes for these pathologies.
Various factors can induce HSP27 gene expression, such as oxidative stress, hormones and hypoxia in diverse cells and tissues (Taylor and Benjamin, 2005) . Hypoxia of the placenta is integral to first trimester trophoblast proliferation. Nevertheless, the role of oxygen in determining the invasive capacity of trophoblast cells has been widely debated (James et al., 2006) . Interestingly, we found that HSP27 is expressed in trophoblast cells in areas of EVT differentiation and in the cytoplasm of EVT cells during their differentiation to motile cells. As placental implantation occurs in a hypoxic microenvironment, this effect might be even more prominent under hypoxic conditions. This issue should be addressed in the future.
In summary, our results demonstrated that HSP27 regulates EVT cell survival, migration and the expression of differentiation markers, as well as factors involved in translation initiation. Altogether it suggests that HSP27 contributes to EVT cell differentiation. Its importance for embryonic development, which is emphasized by the failure to obtain HSP27 knockout mice and its association with pregnancy pathologies, underscores the need for further investigations on this molecule.
